CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- Open-market buys, last 90 days
- $9,705
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,705. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-18 | Holmlin R. Erik President and CEO | Grant or award · Stock Option (Right to Buy) | +290,000 | 290,000 | ||
| 2020-02-18 | Adams Heather Chief Administrative Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-10-23 | TWOMEY CHRISTOPHER J Director | Grant or award | +9,500 | $0.85 | $8K | 19,500 |
| 2019-10-23 | TWOMEY CHRISTOPHER J Director | Grant or award · Common Stock Warrants (right to buy) | +9,500 | $0.01 | $95 | 9,500 |
| 2019-06-06 | Zhou Quan Director | Grant or award · Stock Option (right to buy) | +21,911 | 21,911 | ||
| 2019-06-06 | WANG JUNFENG Director | Grant or award · Stock Option (right to buy) | +21,911 | 21,911 | ||
| 2019-06-06 | TWOMEY CHRISTOPHER J Director | Grant or award · Stock Option (right to buy) | +21,911 | 21,911 | ||
| 2019-06-06 | Luderer Albert Director | Grant or award · Stock Option (right to buy) | +21,911 | 21,911 | ||
| 2019-06-06 | Cai Darren Director | Grant or award · Stock Option (right to buy) | +21,911 | 21,911 | ||
| 2019-06-06 | BARKER DAVID L Director | Grant or award · Stock Option (right to buy) | +21,911 | 21,911 | ||
| 2019-06-06 | Vuori Kristiina MD Director | Grant or award · Stock Option (right to buy) | +30,274 | 30,274 | ||
| 2019-03-01 | Ward Michael James Former Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2019-03-01 | Robinson Warren Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2019-03-01 | OLDAKOWSKI MARK Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2019-03-01 | Holmlin R. Erik President and CEO | Grant or award · Stock Option (Right to Buy) | +145,000 | 145,000 | ||
| 2019-01-18 | Borodkin Mark Chief Operating Officer | Option exercise | +6,000 | $1.30 | $8K | 6,815 |
| 2019-01-18 | Borodkin Mark Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −6,000 | 28,219 | ||
| 2018-10-01 | Borodkin Mark Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +59,590 | 59,590 | ||
| 2018-10-01 | BARKER DAVID L Director | Grant or award · Stock Option (Right to Buy) | +10,516 | 10,516 | ||
| 2018-10-01 | Zhou Quan Director | Grant or award · Stock Option (Right to Buy) | +10,516 | 10,516 |
Page 10 of 14 · 266 trades